May 16, 2025, 12:33 PM
May 16, 2025, 12:33 PM

Avantor announces CFO participation in RBC Capital Markets Global Healthcare Conference

Highlights
  • Brent Jones, Avantor's CFO, will speak at the RBC Capital Markets Global Healthcare Conference in New York.
  • The event is scheduled for May 20, 2025, starting at 8:00 a.m. Eastern Time.
  • Avantor emphasizes its commitment to engaging with stakeholders in the life sciences industry.
Story

On May 16, 2025, Avantor, Inc., a prominent global provider of essential products and services for life sciences and advanced technology sectors, announced its participation in an upcoming conference. This event, the RBC Capital Markets Global Healthcare Conference, will take place in New York on May 20, 2025. Brent Jones, who serves as the Executive Vice President and Chief Financial Officer of Avantor, is scheduled to engage in a fireside chat during the conference at approximately 8:00 a.m. Eastern Time. The RBC Capital Markets Global Healthcare Conference brings together industry leaders and investors from around the globe, providing a platform for discussions on critical issues facing the healthcare sector. Avantor's involvement underscores its commitment to maintaining a strong presence in the life sciences industry and fostering relationships with stakeholders. As noted, the company’s portfolio is employed at over 300,000 customer locations across 180 countries, highlighting its vast influence and operational scope within the market. In addition to the ongoing dialogue around Avantor's strategic positioning, the healthcare conference serves as an opportunity for the executive team to present updates and insights regarding business performance and future direction. Interested parties will have the chance to access the presentation slides and a live audio webcast of the session via Avantor's investor relations website. Following the live webcast, attendees and stakeholders will be able to access the recorded content for a period of 30 days. Avantor's proactive communication strategy reflects its dedication to transparency with investors and its broader audience. This strategic engagement through key conferences reinforces the company's leadership in innovation and excellence in service delivery within the life sciences sector.

Opinions

You've reached the end